Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has been shown to limit hormone responsiveness, but the mechanisms involved in this process are poorly understood. The glucocorticoid receptor is a phosphoprotein that upon ligand binding becomes hyperphosphorylated, and recent evidence indicates that phosphorylation status of the glucocorticoid receptor plays a prominent role in receptor protein turnover. Because phosphorylation is a key signal for ubiquitination and proteasomal catabolism of many proteins, we evaluated whether the ubiquitin-proteasomal pathway had a role in glucocorticoid receptor down-regulation and the subsequent transcriptional response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse glucocorticoid receptor with the proteasome inhibitor MG-132 effectively blocks glucocorticoid receptor protein down-regulation by the glucocorticoid dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor beta-lactone significantly enhanced hormone response of transfected mouse glucocorticoid receptor toward transcriptional activation of glucocorticoid receptor-mediated reporter gene expression. The transcriptional activity of the endogenous human glucocorticoid receptor in HeLa cells was also enhanced by MG-132. Direct evidence for ubiquitination of the glucocorticoid receptor was obtained by immunoprecipitation of cellular extracts from proteasome-impaired cells. Examination of the primary sequence of mouse, human, and rat glucocorticoid receptor has identified a candidate PEST degradation motif. Mutation of Lys-426 within this PEST element both abrogated ligand-dependent down-regulation of glucocorticoid receptor protein and simultaneously enhanced glucocorticoid receptor-induced transcriptional activation of gene expression. Unlike wild type GR, proteasomal inhibition failed to enhance significantly transcriptional activity of K426A mutant GR. Together these findings suggest a major role of the ubiquitin-proteasome pathway in regulating glucocorticoid receptor protein turnover, thereby providing a mechanism to terminate glucocorticoid responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR is ubiquitinated at a conserved lysine residue located at position 419 (Lys-419), and this modification targets the receptor for degradation by the 26S proteasome (Fig.3B)78,79.”
From Corticosteroids (2016) · cites this paper as [79]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Research works printed but not linked: 11
- Sapolsky, 2000, Endocr. Rev., 21, 55
- McKay, 1999, Endocr. Rev., 20, 435
- Bellingham, 1992, Mol. Endocrinol., 6, 2090
- Oakley, 1993, Crit. Rev. Eukaryotic Gene Expr., 3, 63
- Schmidt, 1994, Receptor, 4, 229
- Burnstein, 1994, Mol. Endocrinol., 8, 1764
- Danielsen, 1989, Cancer Res., 49, 2286
- McKay, 2000, Mol. Endocrinol., 14, 1222
- Whitesell, 1996, Mol. Endocrinol., 10, 705
- Vedeckis, 1989, Cancer Res., 49, 2295
- Nawaz, 1999, Cancer Res., 59, 372
Cited by
Items 301–400 of 404
Song, S.-H., Jang, W., Jang, E. Y., Kim, O., Kim, H., Son, T., Choi, D., Lee, S., & Jeong, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.997701 · Cited by 6
“DEXinduced reduced GR expression may be due to a decrease in the half-life of GRmRNA, control of the turnover rate of GR protein, and proteasomal degradation (Dong et al., 1988; Wallace and Cidlowski, 2001).”
BackgroundPra, S. D., Boriati, S., Miano, C., Sacchi, F., Batho, C. A. P., Bongiovanni, C., Bono, I. D., Aharonov, A., Pianca, N., Tassinari, R., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00776-9 · Cited by 5
“2e), consistent with its reduced stability on ligand binding 59 .”
Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis
Chen, L., Ding, L., Wang, X., Huang, Y., & Gao, S. (2023) · mBio · doi:10.1128/mbio.03011-23 · Cited by 5
“As expected, dexamethasone also reduced the total GR protein level in both MM and KMM cells, which was due to proteasome-mediated degradation following signaling activation by ligand binding to the receptor (50).”
BackgroundOrlovsky, M. (2012) · Biopolymers and Cell · doi:10.7124/bc.000061 · Cited by 7
“Similar to the majority of other nuclear receptors, GR is a substrate of the ubiquitin-dependent proteasome degradation [14, 26, 27].”
BackgroundKahles, T., & Vatter, H. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318283ceb4 · Cited by 5
“The expression and functional activity of glucocorticoid receptors in cerebral endothelium is a “conditio sine qua non” in this context (10).”
BackgroundBagnoud, M., Remlinger, J., Joly, S., Massy, M., Salmen, A., Chan, A., Karathanasis, D., Evangelopoulos, M., & Hoepner, R. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14484 · Cited by 4
“39 Interestingly, a T helper subset has also been linked to GC resistance.”
BackgroundWu, C.-J., Livák, F., & Ashwell, J. D. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107581 · Cited by 4
“In particular, the GR is known to undergo ubiquitination-dependent proteasomal degradation under both steady-state conditions and in response to GC stimulation (28 – 30), which serves to restrain its transcriptional effects (28, 30).”
Vrzalová, A., & Vrzal, R. (2024) · Biochimie · doi:10.1016/j.biochi.2024.09.010 · Cited by 4
Popović, N., Ruždijić, S., Kanazir, D. T., Niciforovic, A. P., Adžić, M., Paraskevopoulou, E., Pantelidou, C., Radojcic, M. B., Demonacos, C., & Krstic–Demonacos, M. (2010) · Steroids · doi:10.1016/j.steroids.2010.03.001 · Cited by 5
“We speculate that GR protein levels may be important in the determination of the GR phosphorylation effects [8,27] which may be of special importance in vivo under the conditions of low endogenous hormone levels [36].”
BackgroundLevitt, D. G. (2024) · ADMET & DMPK · doi:10.5599/admet.2414 · Cited by 8
Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells
Chen, G., Lv, S., Pascal, L. E., & Wang, Z. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103577 · Cited by 4
Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Liberman, A. C., Castro, C. N., Antunica-Noguerol, M., Tabarrozzi, A. E. B., Druker, J., Perone, M. J., & ARZT, E. S. (2010) · Current Immunology Reviews · doi:10.2174/1573395511006040371 · Cited by 4
The Ubiquitin Ligase SIAH2 Negatively Regulates Glucocorticoid Receptor Activity and Abundance
Burke, S. J., Taylor, J. L., Batdorf, H. M., Noland, R. C., Burk, D. H., Yu, Y., Floyd, Z. E., & Collier, J. J. (2020) · Biomedicines · doi:10.3390/biomedicines9010022 · Cited by 4
“The GR is known to be ubiquitylated, which controls its degradation [30].”
BackgroundOakley, R. H., & Cidlowski, J. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_4 · Cited by 4
Self-citationNavigating glucocorticoid resistance: From GR isoforms to nuclear condensates
Wang, C., Zhong, Y., Tang, M., He, X., Xu, S., & Zhang, J. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100059 · Cited by 4
Molecular Mechanisms Conferring Resistance/Sensitivity to Glucocorticoid-Induced Apoptosis
Berrou, I., Krstic–Demonacos, M., & Demonacos, C. (2012) · InTech eBooks · doi:10.5772/51467 · Cited by 3
“Regulation of GR transcriptional activity also takes place through ubiquitination and proteasomal degradation of the receptor upon ligand binding [84, 85].”
BackgroundImpact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes
Fuertes, M., Elguero, B., Gonilski‐Pacin, D., Herbstein, F., Rosmino, J., del Giudice, N. C., Fiz, M., Falcucci, L., & ARZT, E. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.864780 · Cited by 3
Blecharz-Lang, K. G., & Burek, M. (2017) · InTech eBooks · doi:10.5772/67025 · Cited by 3
“Ligand‐dependent down‐regulation of the GR, associated with the loss of functional GC responsiveness, was referred in numerous publications [20, 21, 104, 105].”
BackgroundResultWang, J., Zhao, J., Li, J., Wang, F., & Su, Y. (2008) · Shock · doi:10.1097/shk.0b013e3181777c72 · Cited by 3
“Others have indicated that the GR could be targeted for destruction by the ubiquitin-proteasome pathway, which might be ignited by glucocorticoids (23, 24).”
BackgroundYemelyanov, A. Y., Bhalla, P., Ugolkov, A. V., Yang, X. J., & Budunova, I. V. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-3929 · Cited by 3
Jiménez‐Panizo, A., Johnson, T. A., Wagh, K., Alegre‐Martí, A., Montoya-Novoa, I., Lafuente, A. L., Eckhard, U., Rodríguez‐Lumbreras, L. A., Hoang, L., Stortz, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.13.653693 · Cited by 3
Allosteric Regulation and Intrinsic Disorder in Nuclear Hormone Receptors
White, J. T., Motlagh, H. N., Li, J., Thompson, E. B., & Hilser, V. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-18729-7_5 · Cited by 3
Bick, A. J., Avenant, C., Tomasicchio, M., van der Spuy, Z. M., & Hapgood, J. P. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13643 · Cited by 2
Rivers, C. A., Abdulqayoom, H., Kershaw, Y. M., Troy, O. R., Zhao, Z., Conway-Campbell, B. L., & Lightman, S. L. (2025) · Endocrinology · doi:10.1210/endocr/bqaf140 · Cited by 2
Cho, H., Nielsen, M. L., & Olsen, J. V. (2026) · Genome biology · doi:10.1186/s13059-026-03985-4 · Cited by 2
“Following GC treatments, time-dependent increase of GR phosphorylation at Thr-8 and the ubiquitin-mediated protein degradation of the total form were detected [46] (Fig.”
Tang, X., Li, X., Chen, Y., Gao, Y., Yu, P., Xu, L., & Liu, R. (2018) · RSC Advances · doi:10.1039/c7ra12092c · Cited by 2
Mechanisms of Glucocorticoid Actions and Resistance in Multiple Myeloma
Gandhi, V. V., & Sánchez-Vega, B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_23 · Cited by 2
Antunica-Noguerol, M., Aprile-Garcia, F., Budziñski, M. L., Proto-Cassina, L., Liberman, A. C., & ARZT, E. S. (2014) · Advances in Neuroimmune Biology · doi:10.3233/nib-140083 · Cited by 2
“scriptional activity as well [94, 97].”
Macromolecular synthesis inhibitors perturb glucocorticoid receptor trafficking
Dezitter, X., Masselot, B., Tardivel, M., Méreau-Richard, C., Formstecher, P., & Idziorek, T. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.04.008 · Cited by 2
Wang, S., Ekoue, D. N., Raj, G. V., & Kittler, R. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.010 · Cited by 2
Li, Y., Perera, L., He, R. S., Baptissart, M., Petrovich, R. M., & Morgan, M. (2025) · FEBS Journal · doi:10.1111/febs.70137 · Cited by 1
“The 2xGRE-TATA fused to a pGL3 luciferase reporter plasmid (2xGRE-luc) was obtained from Dr Robert Oakley and the mouse GR expression plasmids from Dr Tatsuya Sueyoshi [53,54].”
Glucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines
Cho, H., & Olsen, J. V. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c01188 · Cited by 1
“Glucocorticoid receptor (GR) is known to be hyper-phosphorylated upon ligand binding, and its transcriptional activity is terminated by proteasomal degradation [19].”
From Biomarkers to New Treatments for Post-Traumatic Stress Disorder
Wong, A. H. C., Wang, L., Shen, Y., & Liu, F. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01617-2 · Cited by 1
“In general, GR phosphorylation tends to promote resistance against degradation [42, 43].”
Rhen, T., & Cidlowski, J. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00005-x · Cited by 1
Self-citationMechanisms of Glucocorticoid Receptor Regulation of Gene Expression
Scoltock, A. B., & Cidlowski, J. A. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch6 · Cited by 1
Self-citationCorticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
Toneatto, J., Charó, N. L., Naselli, A., Muñoz-Bernart, M., Lombardi, A., & Piwien‐Pilipuk, G. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101092 · Cited by 1
“GR can be substrate for phosphorylation [83–87], sumoylation [88–92], ubiquitination [93, 94], and acetylation [95].”
BackgroundSchaaf, M. J. M., & Meijer, O. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00029-2 · Cited by 2
Mata‐Greenwood, E., Chow, W. L., Anti, N. A. O., Sands, L. D., Adeoye, O. O., Ford, S. P., & Nathanielsz, P. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042311 · Cited by 1
“Although glucocorticoids are well known to induce GR protein proteasomal degradation [34], dexamethasone had no significant effect on GR protein levels in ShUVECs (Figure 1A–”
BackgroundWehmeyer, L. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
THE ROLE OF LIGAND IN THE INTERACTION OF ANDROGEN RECEPTOR WITH DNA AND COACTIVATORS
Karvonen, U. (2003) · Helda - University of Helsinki Institutional Repository · Cited by 1
Hadley, K. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 2
Progesterone Receptor Isoforms : functional Selectivity and Pharmacological Targeting
Khan, J. A. (2011) · theses.fr (ABES) · doi:10.70675/d565fcfezaed8z42f4za43az5b89ba52f3ae · Cited by 1
Sidoroff, M. (2010) · Helda - University of Helsinki Institutional Repository
Bush, K. A. (2011) · Loyola eCommons (Loyola University of Chicago)
Glucocorticoid receptor activation by long acting steroids and its modification by inflammation
Yang, J.-Q. (2007) · edoc (University of Basel) · doi:10.5451/unibas-004365943 · Cited by 1
Interaktionen zwischen dem Peptidhormon Relaxin und dem humanen Glukokortikoidrezeptor
Greinwald, M. P. (2006) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15518
The role of ubiquitylation and acetylation in androgen receptor function
Giménez, H. F. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5257
Regulation of Estrogen Receptor alpha Ubiquitination and Proteasome-mediated Receptor Degradation
Berry, N. B. (2008) · IUScholarWorks (Indiana University) · Cited by 1
Glucocorticoid Receptor Function and Hormone Therapy Resistance
van Geffen, J. P. (2013) · Utrecht University Repository (Utrecht University)
Ghizoni, H. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2012.tde-13112012-095702
Der epitheliale Natrium-Kanal (ENaC)
Bergann, T. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13144
Harashima, M., Hyuga, M., Nagaoka, Y., Saito, C., Furukawa, M., Seki, T., Ariga, T., Kawasaki, N., & Niimi, S. (2012) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2012.34043
Molecular Mechanisms of Glucocorticoid Receptor Action
Bhavsar, P. K., & Adcock, I. M. (2008) · Wiley eBooks · doi:10.1002/9780470985731.ch1
Molecular mechanisms of glucocorticoid resistance in childhood acute lymphoblastic leukemia
Tissing, W. J. E. (2006) · RePub (Erasmus University Rotterdam)
Modulation of folate receptor-α by glucocorticoid receptor and progesterone receptor.
Tran, T. (2005) · Europe PMC (PubMed Central)
MOLECULAR DETERMINANTS OF ANDROGEN ACTION
Santti, H. (2004) · Helda - University of Helsinki Institutional Repository
ANDROGEN RECEPTOR IN TRANSCRIPTIONAL REGULATION AND CARCINOGENESIS
Kang, Z. (2006) · Helda - University of Helsinki Institutional Repository
Function of PIAS proteins in steroid receptor-dependent signaling
Kotaja, N. (2002) · Helda - University of Helsinki Institutional Repository
Current perspectives Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., Adcock, I. M., & Kingdom, U. (2006)
Shatnawi, A. A. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Modulation of GR transcriptional signalling by HIV-1 Vpr: insights into regulation by progestins
Grantham, N. J. (2012) · Open University of Cape Town (University of Cape Town) · Cited by 2
Mitochondria and energetics stress : signaling pathways and cellular adaptations.
Desquiret‐Dumas, V., & Malthièry, Y. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Wei, H. (2003) · Repository KITopen (Karlsruhe Institute of Technology) · doi:10.5445/ir/4582003
“68 expressing the mouse GR with the proteasome inhibitor MG132 inhibited dexamethasone-induced downregulation of the receptor, and result in enhanced transactivation activity of the receptor (Wallace and Cidlowski, 2001), indicating that the proteasome is involved in hormone induced GR degradation.”
BackgroundIdentifizierung und Charakterisierung von Interaktionspartnern des Transkriptionsfaktors AATF
Fakultät, M.-N., & Friedrich-Wilhelms-Universität, R. (2003)
Non‐Targeted Therapeutics for Inflammatory Bowel Diseases
Rogler, G. (2010) · Wiley eBooks · doi:10.1002/9781444318418.ch24
Prenzel, T. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-443
An investigation of glucocorticoid and serotonergic systems in human placenta
Bivol, S. (2018) · Griffith Research Online · doi:10.25904/1912/494
Acevedo, A. (2019) · doi:10.7282/t3-edxt-vd06
“Other pathways maintained a strictly monophasic response (beta-Alanine 55 metabolism, Glutathione metabolism, Proteasome, and Retinol metabolism) to both acute and chronic MPL administration.”
BackgroundInfluentialKuipa, M. (2019) · Open University of Cape Town (University of Cape Town)
Genome-wide regulation of glucocorticoid signaling by SUMO modifications
Paakinaho, V. (2014) · UEF eRepo (University of Eastern Finland)
Zhang, C., Dong, X., Mao, W., Wang, C., Ma, B., Hu, L., & Chen, R. (2021) · PubMed Central · Cited by 1
Balancing Strategies: GC and GILZ Axis
Nataraja, C., Zhu, W., Dankers, W., & Jones, S. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-85161-3_10
Carrigan, A. (2011) · Library and Archives Canada (Government of Canada) · doi:10.20381/ruor-4388
Nuclear Mechanisms of Glucocorticoid Action
Hager, G. L., Stavreva, D. A., & Voss, T. C. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00040-1 · Cited by 1
Webb, P. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1027380.329507
Stability of Steroid Hormone Receptors
Gale-Day, Z. J., & Gestwicki, J. E. (2022) · Wiley eBooks · doi:10.1002/9781119774198.ch2
Ron, E., Popinga, A., Forman, J., Aguilera, L. U., Forero-Quintero, L. S., & Munsky, B. E. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.2525
Lee, K. H., & Magoski, N. S. (2025) · The Journal of Physiology · doi:10.1113/jp289468
“Note that lactacystin can also suppress breakdown of mammalian receptors (Wallace & Cidlowski, 2001; Zhang et al., 2009).”
Gan, Y.-L., Wang, C.-Y., He, R.-H., Hsu, P.-C., Yeh, H.-H., Hsieh, T.-H., Lin, H.-C., Cheng, M.-Y., Jeng, C.-J., Huang, M.-C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20076665
Understanding roles for PARP1 in skeletal muscle
Tan, A. (2023) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · Cited by 1
de Almeida, I. A. F. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Contrôle de la masse fonctionnelle des cellules β pancréatiques par les glucocorticoïdes et pgc-1α
Besseiche, A. (2015) · theses.fr (ABES) · doi:10.70675/f16ecd6fza687z4a5fzac34zc26774dc9c3f
Glial glucocorticoid geceptors in parkinsonism
Maatouk, L. (2015) · theses.fr (ABES) · doi:10.70675/1256b391z3e4fz471bz8360ze0eee3d095a8
IMPACT DE L’HYPERCORTICISME SUR L’AXE GONADOTROPE FEMELLE
Ayrout, M. (2018) · theses.fr (ABES) · doi:10.70675/194a6ff5z99f6z4ef0z800ez5473528e7a30 · Cited by 1
Implication du récepteur des glucocorticoïdes en physiopathologie humaine
Vitellius, G. (2019) · theses.fr (ABES) · doi:10.70675/84630f11zbc82z43a6z8604z69024f4ae7dd
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
Delangre, E. (2021) · theses.fr (ABES) · doi:10.70675/622d48edz59dcz427ez85c9z9da5f8129e84
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Metadata
- Authors
- Wallace, A. D., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- ORCID
- Cidlowski, John A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 46
- Pages
- 42714-42721
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984573021
- Cited by
- 394
- References
- 65
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 12 · 2017: 14 · 2016: 10 · 2015: 16 · 2014: 15 · 2013: 25 · 2012: 19
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6924 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- glucocorticoid receptor, receptor down-regulation, ubiquitin-proteasome system, proteasome inhibition, MG132, dexamethasone, receptor phosphorylation, ubiquitination, transcriptional activation, hormone responsiveness
- MeSH terms
- Animals, Cysteine Endopeptidases, Dexamethasone, Glucocorticoids, HeLa Cells, Humans, Ligands, Luciferases, Lysine, Multienzyme Complexes, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Receptors, Glucocorticoid, Time Factors, Transcription, Genetic, Transfection, Blotting, Western, Signal Transduction, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, COS Cells, Amino Acid Motifs, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.